NEW YORK (GenomeWeb) – Helena Biosciences said today that it is collaborating with Ghent University to commercialize a glycoprotein-based blood test for chronic liver disease.

Called the Glyco Liver Profile, the test uses capillary electrophoresis to measure glycosylation of serum proteins, and uses this information to diagnose and monitor chronic liver diseases such as hepatic inflammation, fibrosis, and cirrhosis. The test also assesses cirrhosis patients' risk of developing liver cancer within the next five years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.